PubMed

Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability.

Widengård I, Mäepea O, Alm A.

Br J Ophthalmol. 1998 Apr;82(4):404-6.PMID: 9640189 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of latanoprost 0.005% once daily versus 0.0015% twice daily on intraocular pressure and aqueous humour protein concentration in glaucoma patients. A randomized, double-masked comparison with timolol 0.5%.

Diestelhorst M, Roters S, Krieglstein GK.

Graefes Arch Clin Exp Ophthalmol. 1997 Jan;235(1):20-6.PMID: 9034838 [PubMed - indexed for MEDLINE]Related articles

Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure.

Kimal Arici M, Topalkara A, Güler C.

Int Ophthalmol. 1998;22(1):37-42.PMID: 10090447 [PubMed - indexed for MEDLINE]Related articles

Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.

Aung T, Chew PT, Oen FT, Chan YH, Thean LH, Yip L, Lim BA, Soh J, Seah SK.

Br J Ophthalmol. 2002 Jan;86(1):75-9. Erratum in: Br J Ophthalmol 2002 Jun;86(6):707. PMID: 11801508 [PubMed - indexed for MEDLINE]Related articlesFree article

The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.

Diestelhorst M.

Graefes Arch Clin Exp Ophthalmol. 2000 May;238(5):433-9.PMID: 10901475 [PubMed - indexed for MEDLINE]Related articles

Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure.

Rulo AH, Greve EL, Hoyng PF.

Ophthalmology. 1997 Sep;104(9):1503-7.PMID: 9307648 [PubMed - indexed for MEDLINE]Related articles

Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma.

Saito M, Takano R, Shirato S.

Am J Ophthalmol. 2001 Oct;132(4):485-9.PMID: 11589867 [PubMed - indexed for MEDLINE]Related articles

Effects on IOP restoration and blood-aqueous barrier after long-term treatment with latanoprost in open angle glaucoma and ocular hypertension.

Lindén C, Nuija E, Alm A.

Br J Ophthalmol. 1997 May;81(5):370-2.PMID: 9227201 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial.

DuBiner HB, Mroz M, Shapiro AM, Dirks MS; Brimonidine vs. Latanoprost Study Group.

Clin Ther. 2001 Dec;23(12):1969-83.PMID: 11813932 [PubMed - indexed for MEDLINE]Related articles

A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.

Maul E, Carrasco FG, Costa VP, Casiraghi JF, Vargas E, Sarmina JS, Mayol R.

Clin Ther. 2007 Sep;29(9):1915-23.PMID: 18035191 [PubMed - indexed for MEDLINE]Related articles

Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.

García Sanchez J.

Eur J Ophthalmol. 2000 Jul-Sep;10(3):198-204.PMID: 11071026 [PubMed - indexed for MEDLINE]Related articles

Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.

Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR.

Ann Pharmacother. 2008 Apr;42(4):498-504. Epub 2008 Mar 25.PMID: 18364402 [PubMed - indexed for MEDLINE]Related articles

Latanoprost : an update of its use in glaucoma and ocular hypertension.

Perry CM, McGavin JK, Culy CR, Ibbotson T.

Drugs Aging. 2003;20(8):597-630. Review.PMID: 12795627 [PubMed - indexed for MEDLINE]Related articles

The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension.

Stewart WC, Day DG, Stewart JA, Schuhr J, Latham KE.

Am J Ophthalmol. 2001 May;131(5):631-5.PMID: 11336939 [PubMed - indexed for MEDLINE]Related articles

Comparison of the intraocular pressure lowering effect of latanoprost and carteolol-pilocarpine combination in newly diagnosed glaucoma.

Ozdemir M, Ozdemir G.

Jpn J Ophthalmol. 2003 Jan-Feb;47(1):72-6.PMID: 12586182 [PubMed - indexed for MEDLINE]Related articles

Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.

Simmons ST, Samuelson TW.

Clin Ther. 2000 Apr;22(4):388-99.PMID: 10823361 [PubMed - indexed for MEDLINE]Related articles

Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece.

Petounis A, Mylopoulos N, Kandarakis A, Andreanos D, Dimitrakoulias N.

J Glaucoma. 2001 Aug;10(4):316-24.PMID: 11558817 [PubMed - indexed for MEDLINE]Related articles

Combined therapy of pilocarpine or latanoprost with timolol versus latanoprost monotherapy.

Diestelhorst M, Nordmann JP, Toris CB.

Surv Ophthalmol. 2002 Aug;47 Suppl 1:S155-61. Review.PMID: 12204713 [PubMed - indexed for MEDLINE]Related articles

Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias.

Miyake K, Ota I, Maekubo K, Ichihashi S, Miyake S.

Arch Ophthalmol. 1999 Jan;117(1):34-40.PMID: 9930158 [PubMed - indexed for MEDLINE]Related articles

Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma.

Pillunat LE, Larsson LI; European and Canadian Latanoprost Study Group.

Br J Ophthalmol. 2003 Dec;87(12):1492-6.PMID: 14660460 [PubMed - indexed for MEDLINE]Related articlesFree article